Search research articles
Contact Us
Filters
Showing results (1041-1050 of 1,155) with videos related to
Page
of 116
Sort By:
Blood
|
March 8, 2019
Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab
John C Byrd, Peter Hillmen, Susan O'Brien, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 6, 2025
The Pelvic Rosetta Classification Project: An Interdisciplinary Proposal for a Lymph Node Map of the Pelvis in Prostate Cancer
Gernot Ortner, Xenia Hoderlein, Francesco Barbato, et al.
Bone Marrow Transplantation
|
September 6, 2016
Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLL
I F Khouri, D Sui, E J Jabbour, et al.
Leukemia & Lymphoma
|
April 20, 2022
A multi-arm phase Ib/II study designed for rapid, parallel evaluation of novel immunotherapy combinations in relapsed/refractory acute myeloid leukemia
Nicholas J Short, Gautam Borthakur, Naveen Pemmaraju, et al.
Diseases of the Colon and Rectum
|
June 15, 2026
Cost-Effectiveness of Pelvic Floor Reconstruction Using Biological Mesh After Extralevator Abdominoperineal resection for Rectal Cancer
Rudolf van den Berg, Gijsbert D Musters, Cornelis Verhoef, et al.
Iscience
|
September 14, 2022
Recent infection with HCoV-OC43 may be associated with protection against SARS-CoV-2 infection
A H Ayesha Lavell, Jonne J Sikkens, Arthur W D Edridge, et al.
British Journal of Haematology
|
December 4, 2018
Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis
Jennifer R Brown, Javid Moslehi, Michael S Ewer, et al.
American Journal of Hematology
|
August 22, 2018
Single-agent ibrutinib versus chemoimmunotherapy regimens for treatment-naïve patients with chronic lymphocytic leukemia: A cross-trial comparison of phase 3 studies
Tadeusz Robak, Jan A Burger, Alessandra Tedeschi, et al.
Iscience
|
November 28, 2022
Co-display of diverse spike proteins on nanoparticles broadens sarbecovirus neutralizing antibody responses
Mitch Brinkkemper, Tim S Veth, Philip J M Brouwer, et al.
JAMA Oncology
|
March 29, 2019
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial
Wolfgang P Fendler, Jeremie Calais, Matthias Eiber, et al.
Page
of 116
Search research articles
Search
Showing results (1041-1050 of 1,155) with videos related to
Sort By:
Page
of 116
Blood
|
March 8, 2019
Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab
John C Byrd, Peter Hillmen, Susan O'Brien, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 6, 2025
The Pelvic Rosetta Classification Project: An Interdisciplinary Proposal for a Lymph Node Map of the Pelvis in Prostate Cancer
Gernot Ortner, Xenia Hoderlein, Francesco Barbato, et al.
Bone Marrow Transplantation
|
September 6, 2016
Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLL
I F Khouri, D Sui, E J Jabbour, et al.
Leukemia & Lymphoma
|
April 20, 2022
A multi-arm phase Ib/II study designed for rapid, parallel evaluation of novel immunotherapy combinations in relapsed/refractory acute myeloid leukemia
Nicholas J Short, Gautam Borthakur, Naveen Pemmaraju, et al.
Diseases of the Colon and Rectum
|
June 15, 2026
Cost-Effectiveness of Pelvic Floor Reconstruction Using Biological Mesh After Extralevator Abdominoperineal resection for Rectal Cancer
Rudolf van den Berg, Gijsbert D Musters, Cornelis Verhoef, et al.
Iscience
|
September 14, 2022
Recent infection with HCoV-OC43 may be associated with protection against SARS-CoV-2 infection
A H Ayesha Lavell, Jonne J Sikkens, Arthur W D Edridge, et al.
British Journal of Haematology
|
December 4, 2018
Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis
Jennifer R Brown, Javid Moslehi, Michael S Ewer, et al.
American Journal of Hematology
|
August 22, 2018
Single-agent ibrutinib versus chemoimmunotherapy regimens for treatment-naïve patients with chronic lymphocytic leukemia: A cross-trial comparison of phase 3 studies
Tadeusz Robak, Jan A Burger, Alessandra Tedeschi, et al.
Iscience
|
November 28, 2022
Co-display of diverse spike proteins on nanoparticles broadens sarbecovirus neutralizing antibody responses
Mitch Brinkkemper, Tim S Veth, Philip J M Brouwer, et al.
JAMA Oncology
|
March 29, 2019
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial
Wolfgang P Fendler, Jeremie Calais, Matthias Eiber, et al.
Page
of 116